PeraHealth, a Charlotte, N.C.-based provider of predictive, real-time clinical surveillance solutions, closed $14m in financing.
Mainsail Partners, a growth equity firm, provided the financing.
The company intends to use the funds to grow its internal team in the areas of customer service and clinical adoption, to support ongoing research and development efforts to grow its existing product offerings, with the addition of PeraWatch, a telehealth and remote monitoring solution, and PeraMobile, an app which tracks and identifies at-risk patients for clinicians on the go.
Led by Stephanie Alexander, CEO, PeraHealth provides clinical surveillance solutions which leverage the Rothman Index, a validated patient acuity score, to enable healthcare providers to identify at-risk patients for earlier intervention.
The company’s solutions – in use by more than 80 hospitals and care providers – help determine when to discharge patients; prioritize patient bedside visits and nursing assignments; improve documentation accuracy and timeliness; optimize ICU bed use; and identify opportunities for palliative care consults.
They Products are integrated with all major EHR vendors, enabling care providers to monitor patients at the unit, hospital and system-level.
Customers include Yale New Haven Health System, Houston Methodist, Children’s Hospital of Philadelphia, Memorial Sloan Kettering Cancer Center, and Mission Health.